BOCKORNY GROUP, INC. for ANIMAL HEALTH INSTITUTE
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Transatlantic Trade and Investment Partnership (no specific legislation) Issues related to the North America Free Trade Agreement - no specific legislation United States-Mexico-Canada Agreement
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL FERNANDEZ | — |
| BLAIR C LARKINS | — |
| PAUL SCOTT SHEARER | — |
Health Issues HCR
Issues related to antibiotic research H.R.1587 - Preservation of Antibiotics for Medical Treatment Act of 2017
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL FERNANDEZ | — |
| BLAIR C LARKINS | — |
| PAUL SCOTT SHEARER | — |
Budget/Appropriations BUD
S.2976/H.R.5961 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY'19 (APHIS and FDA) H.R.1625 - Consolidated Appropriations Act of 2018 (Antibiotics and Animal Health) - no specific legislation S.2434/H.R.5554 - Animal Drug and Animal Generic Drug User Fee Amendments of 2018
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL FERNANDEZ | — |
| BLAIR C LARKINS | — |
| PAUL SCOTT SHEARER | — |
Animals ANI
Issues related to animal health, antibiotics and food safety H.R.1587 - Preservation of Antibiotics for Medical Treatment Act of 2017 Issues related to National Environmental Policy Act Implementing Procedures - no specific legislation Implementation of biotechnology policy - no specific legislation S.2434 - Animal Drug & Animal Generic Drug User Fee Amendments 2018
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL FERNANDEZ | — |
| BLAIR C LARKINS | — |
| PAUL SCOTT SHEARER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.